APT Medical Inc.

Shanghai Stock Exchange 688617.SS

APT Medical Inc. Free Cash Flow for the year ending December 31, 2023: USD 68.60 M

APT Medical Inc. Free Cash Flow is USD 68.60 M for the year ending December 31, 2023, a 111.10% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

APT Medical Inc. Free Cash Flow for the year ending December 31, 2022 was USD 32.50 M, a 1,373.74% change year over year.
APT Medical Inc. Free Cash Flow for the year ending December 31, 2021 was USD 2.21 M, a -86.17% change year over year.
APT Medical Inc. Free Cash Flow for the year ending December 31, 2020 was USD 15.94 M, a 976.28% change year over year.
APT Medical Inc. Free Cash Flow for the year ending December 31, 2019 was USD -1.82 M, a 7.77% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688617.SS

APT Medical Inc.

CEO	Mr. Zhenghui Cheng
IPO Date	Jan. 7, 2021
Location	China
Headquarters	601, Building B
Employees	2,155
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.

Key trends

Past 5 years